Javascript must be enabled to continue!
Cognitive and behavioral changes in amyotrophic lateral sclerosis
View through CrossRef
BACKGROUND. Amyotrophic lateral sclerosis (ALS) is not limited only to motor impairment, and can also manifest with cognitive and behavioral disorders. Currently these presentations of ALS are unrecognized. Hence the research of ALS variants with cognitive and behavioral impairments is necessary.
AIM. To study the frequency and clinical characteristics of ALS variants with cognitive and behavioral impairments.
MATERIAL AND METHODS. The patients were recruited in 20202021. All patients with definite and possible ALS according to El Escorial criteria were included. The Edinburgh Cognitive and Behavioral ALS Screen (ECAS) was used to assess cognitive and behavioral changes. 44 patients, 26 males and 18 females, aged 39 to 77 years (median of age 61 years, interquartile range 53.574.5). Statistical analysis was performed using IBM SPSS Statistics 21. Continuous data were analyzed using the MannWhitney test, categorical data was analyzed by exact Fisher criteria. A p-value less than 0.05 was statistically significant.
RESULTS. In 43.2% of patients cognitive and/or behavioral changes were observed. The majority of patients (approximately 20%) suffered from a variant of ALS with cognitive impairment, which was mostly presented with executive and social cognitive dysfunction. ALS with behavioral impairment was observed at 9% of patients, which mostly presented with apathy and disinhibition. A combination of cognitive and behavioral impairment was registered in 7% of patients. In another 7% of patients severity of cognitive and behavioral impairment reached a degree of dementia and corresponded to frontotemporal degeneration.
CONCLUSION. This cognitive and behavioral impairment is observed in a substantial number of patients with ALS and mostly presented with moderate executive and social cognitive dysfunction, as well as apathy and less often disinhibition.
Title: Cognitive and behavioral changes in amyotrophic lateral sclerosis
Description:
BACKGROUND.
Amyotrophic lateral sclerosis (ALS) is not limited only to motor impairment, and can also manifest with cognitive and behavioral disorders.
Currently these presentations of ALS are unrecognized.
Hence the research of ALS variants with cognitive and behavioral impairments is necessary.
AIM.
To study the frequency and clinical characteristics of ALS variants with cognitive and behavioral impairments.
MATERIAL AND METHODS.
The patients were recruited in 20202021.
All patients with definite and possible ALS according to El Escorial criteria were included.
The Edinburgh Cognitive and Behavioral ALS Screen (ECAS) was used to assess cognitive and behavioral changes.
44 patients, 26 males and 18 females, aged 39 to 77 years (median of age 61 years, interquartile range 53.
574.
5).
Statistical analysis was performed using IBM SPSS Statistics 21.
Continuous data were analyzed using the MannWhitney test, categorical data was analyzed by exact Fisher criteria.
A p-value less than 0.
05 was statistically significant.
RESULTS.
In 43.
2% of patients cognitive and/or behavioral changes were observed.
The majority of patients (approximately 20%) suffered from a variant of ALS with cognitive impairment, which was mostly presented with executive and social cognitive dysfunction.
ALS with behavioral impairment was observed at 9% of patients, which mostly presented with apathy and disinhibition.
A combination of cognitive and behavioral impairment was registered in 7% of patients.
In another 7% of patients severity of cognitive and behavioral impairment reached a degree of dementia and corresponded to frontotemporal degeneration.
CONCLUSION.
This cognitive and behavioral impairment is observed in a substantial number of patients with ALS and mostly presented with moderate executive and social cognitive dysfunction, as well as apathy and less often disinhibition.
Related Results
Urinary biomarkers for amyotrophic lateral sclerosis: candidates, opportunities and considerations
Urinary biomarkers for amyotrophic lateral sclerosis: candidates, opportunities and considerations
Abstract
Amyotrophic lateral sclerosis is a relentless neurodegenerative disease that is mostly fatal within 3–5 years and is diagnosed on evidence of progressive up...
User Experience of Cognitive Behavioral Therapy Apps for Depression: An Analysis of App Functionality and User Reviews (Preprint)
User Experience of Cognitive Behavioral Therapy Apps for Depression: An Analysis of App Functionality and User Reviews (Preprint)
BACKGROUND
Hundreds of mental health apps are available to the general public. With increasing pressures on health care systems, they offer a potential way ...
Hydatid Cyst of The Orbit: A Systematic Review with Meta-Data
Hydatid Cyst of The Orbit: A Systematic Review with Meta-Data
Abstarct
Introduction
Orbital hydatid cysts (HCs) constitute less than 1% of all cases of hydatidosis, yet their occurrence is often linked to severe visual complications. This stu...
Clinical features of fatigue in amyotrophic lateral sclerosis
Clinical features of fatigue in amyotrophic lateral sclerosis
Background. Fatigue (athenia) is widely spread among patients with neurological disorders. It substantially reduces patients’ quality of life. Its clinical features and mechanisms ...
Evaluation of quality of life and mood disorders in caregivers of patients with amyotrophic lateral sclerosis: A single-center cross-sectional study
Evaluation of quality of life and mood disorders in caregivers of patients with amyotrophic lateral sclerosis: A single-center cross-sectional study
Background: Caregivers of patients with amyotrophic lateral sclerosis (ALS) may suffer from anxiety, depression, and reduced quality of life (QoL). Our goal was to evaluate the QoL...
Mast cells and neuroinflammation in pathogenesis of neurologic and psychiatric diseases
Mast cells and neuroinflammation in pathogenesis of neurologic and psychiatric diseases
The review summarizes current data on the role of neuroinflammation and mast cells in the pathogenesis of nervous and mental diseases, such as multiple sclerosis, Alzheimers diseas...
Narrative review based on fingolimod therapy in pediatric MS
Narrative review based on fingolimod therapy in pediatric MS
The course of pediatric-onset multiple sclerosis and adult multiple sclerosis shows some clinical differences. The rate of having a second attack after the first clinical event is ...
Midlife Marital Status and Subsequent Cognitive Decline over 20 Years: Discovery from ARIC
Midlife Marital Status and Subsequent Cognitive Decline over 20 Years: Discovery from ARIC
Background — Recent studies show that marriage is associated with a protective effect against cognitive decline among older adults. However, definite evidence from large prospectiv...

